Life Science Intelligence partners with Opus Origin to accelerate the expansion of its premium global platforms for medtech innovation and investment Strategic investment supports the continued ...

Next-generation upgrade strengthens data comparability and compliance—without changing trusted instrumentation ...

Luma Group has closed its inaugural life sciences venture capital fund, LumaBio Fund I, with $410 million in committed ...

Dual recognition in 2026 Frost Radar™ reports marks a fourth consecutive year of Frost Radar leadership for LabVantage.

Caris Life Sciences' Q2 featured accelerating clinical volumes, 68% gross margin, and strong early traction for Caris Detect.

Janus Henderson Global Life Sciences Fund returned 12.80% and the MSCI World Health Care Index returned 6.75%.

Wall Street projects the company turning a net profit of 12 cents a share this year.

Artificial intelligence is moving into increasingly specialized areas of life sciences, where communicating complex scie ...

Life sciences companies have long relied on evergreening strategies to strengthen patent exclusivity around innovative therapies.

BioTech Social Inc. (BSI) has established an advisory board of experts from various fields to enhance financial ...

Buoyed by the rapid development of COVID-19 vaccines, the life sciences industry is on track for a succession of upheavals already transforming patient care, business models, and market dynamics. In ...

BioAlberta is honoured to announce the recipients of the 2026 Achievement Awards at the Health and Life Sciences Showcase and Awards Dinner in Calgary on September 24 th, 2026. This year’s award ...